FDA Inspection 1012286 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on February 2, 2017 in Fort Walton Beach, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 2, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Walton Beach, FL (United States)